Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Personalised Medicine, the evolution of healthcare for improving people’s lives

Project description

Paving the way for personalised medicine

In the complex landscape of healthcare, the one-size-fits-all approach falls short, leaving room for inefficiencies and missed opportunities in patients' well-being. In this context, the EU-funded PM4Future project aims to organise a conference on personalised medicine under the auspices of the Spanish Presidency of the Council of the European Union that will take place in Valencia during the first week of October 2023. The conference will be divided into three main axes: 1) personalised approach to prevention, diagnosis, and treatment; 2) infrastructures and data platforms for personalised medicine; and 3) international cooperation for personalised medicine. The conference will tackle the challenges and opportunities of implementing personalised medicine in healthcare. This initiative is set to be a vital stepping stone in the journey towards a future where healthcare is truly tailored to each individual.

Objective

The project PM4Future aims at organising a Conference on Personalised Medicine with the overarching objective of identifying challenges and opportunities for the implementation of personalised medicine in the healthcare as well as gaps on research and funding. The event, organised by the Spanish Foundation for Science and Technology (FECYT), on behalf of the Spanish Ministry of Science and Innovation (MCIN) and with collaboration of the Institute of Health Carlos III (ISCIII), the Centre for the Development of Technology and Innovation (CDTI), will be held on October the 4th and 5th 2023 in Valencia.

The agenda will focus on three main axes: 1) Prevention, diagnostics and treatment of diseases through a personalised approach; 2) Tools for Personalised Medicine: the role of federated transnational research infrastructures in the research and development of PM; and 3) International cooperation as an element to promote the development of Personalised medicine in African and Latin American regions.

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-HLTH-2023-PSPA-10-IBA

See all projects funded under this call

Coordinator

FUNDACION ESPANOLA PARA LA CIENCIAY LA TECNOLOGIA, F.S.P., FECYT
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 300 000,00
Address
CALLE DEL PINTOR MURILLO NUMERO 15
28100 ALCOBENDAS
Spain

See on map

Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 341 836,25
My booklet 0 0